Evaluating candidate lead compounds by rapid analysis of drug interactions with human serum albumin

American Biotechnology Laboratory

Volumn 26, Issue 5, 2008, Pages 14-16

  Bronner, Vered ^a   Nahshol, Oded ^a   Bravman, Tsafrir ^a  

^a BIO RAD LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 53849132398     PISSN: 07493223     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Bertucci, C.; Domenici, E. Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance. Curr. Med. Chem. 2002, 9, 1463-81.
2. Rich, R.L.; Day, Y.S.N.; Morton, T.A.; Myszka, D.G. High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using Biacore. Anal. Biochem. 2001, 296, 197-207.
3. Day, Y.S.N.; Myszka, D.G. Characterizing a drug's primary binding site on albumin. J. Pharm. Sci. 2003, 92, 333-43.
4. Bravman, T.; Bronner, V.; Lavie, K.; Notcovich, A.; Papalia, G.A.; Myszka, D.G. Exploring "One-shot" Kinetics and small molecule analysis using the ProteOn XPR36 array biosensor. Anal. Biochem. 2006, 358, 281-8.